| MeSH term | MeSH ID | Detail |
|---|---|---|
| Atherosclerosis | D050197 | 85 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Martrat A et al. | Altered systemic and tissue prostacyclin in cerulein induced acute pancreatitis in rats. | 1992 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:1384068 |
| Hiramatsu M et al. | Application of an alpha-sidechain length-specific monoclonal antibody to immunoaffinity purification and enzyme immunoassay of 2,3-dinor-6-keto-prostaglandin F1 alpha from human urine. | 1994 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8171070 |
| van der Weiden RM et al. | Prostanoid excretion before in vitro fertilization relates to the likelihood of pregnancy. | 1995 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8821123 |
| Stichtenoth DO et al. | Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease. | 2001 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:11728174 |
| Pancera P et al. | Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8860111 |
| Rossi P et al. | Percutaneous transluminal angioplasty increases thromboxane A2 production in claudicants. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9175173 |
| Rossi P et al. | Prostacyclin and thromboxane A2 synthesis are increased in acute lower limb ischaemia. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9014222 |
| Hishinuma T et al. | Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. | 2001 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:11728171 |
| Sinzinger H | Comments on "Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications". | 2002 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12445490 |
| Delemarre FM et al. | Urinary prostaglandin excretion in pregnancy: the effect of dietary sodium restriction. | 2000 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:11049696 |
| Hishinuma T et al. | Analysis of the thromboxane/prostacyclin balance in human urine by gas chromatography/selected ion monitoring: abnormalities in diabetics. | 1996 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8888357 |
| Mizugaki M et al. | Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593167 |
| Hishinuma T et al. | Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593168 |
| Hoch B and Bernhard M | Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593170 |
| Blatnik M and Steenwyk RC | Quantification of urinary PGEm, 6-keto PGF(1alpha) and 2,3-dinor-6-keto PGF(1alpha) by UFLC-MS/MS before and after exercise. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20416393 |
| Lynch CM et al. | The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. | 2011 | Prostaglandins Other Lipid Mediat. | pmid:21723954 |
| Rosenkranz B et al. | Urinary and systemic metabolites of prostacyclin in the perfused rabbit kidney. | 1982 | Ren Physiol | pmid:6750728 |
| Vesterqvist O et al. | Synthetic arterial grafts cause prolonged increase in the in vivo formation of thromboxane and prostacyclin in humans. | 1987 | Res Exp Med (Berl) | pmid:3303204 |
| Tanaka H et al. | Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients? | 1999 | Respir Med | pmid:10653051 |
| Vesterqvist O et al. | In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty. | 1988 | Scand. J. Clin. Lab. Invest. | pmid:3375779 |